We’re Heading to Advanced Therapies Europe in Barcelona

We’re Heading to Advanced Therapies Europe in Barcelona

We are excited to announce that our team will be attending Advanced Therapies Europe 2025 in Barcelona, one of the most important gatherings for the advanced therapies and regenerative medicine community.

This event brings together leading experts, biotech innovators, CDMOs, investors, and healthcare professionals to discuss the latest trends in cell and gene therapies, non-viral delivery technologies, and the future of advanced medicines.

The 2025 edition will explore crucial topics such as the clinical development pathways for ATMPs, the evolving regulatory landscape in Europe and beyond, the challenges of GMP manufacturing and large-scale production, and the importance of building robust supply chain and logistics solutions to ensure timely delivery of therapies to patients. In addition, the conference will address the role of innovative financing models, cross-sector partnerships, and investment strategies in accelerating the growth of the advanced therapies market.

For us, participating in Advanced Therapies Europe is not only an opportunity to stay at the forefront of scientific and technological innovation, but also to connect with key stakeholders and explore potential collaborations that can accelerate the development and delivery of life-changing therapies.

Location: Barcelona

Dates: September 2–4, 2025

We look forward to engaging in insightful discussions, sharing our vision, and learning from the international community of pioneers shaping the future of healthcare.

Stay tuned for updates from the event!

image Advanced Therapies Europe in Barcelona
1200 900 Anemocyte.com

Anemocyte S.r.l. Single Shareholder Private Limited-Liability Company
Via R. Lepetit, 34 21040 Gerenzano (VA) Italy | Ph: +39 02 99372311 – Fax: +39 02 99372313 | Anemocyte Inc. 1221 Brickell Avenue, Suite 1160 Miami FL 33131

VAT number: 12914940155 | Share capital € 530.000,00 fully paid | R.E.A. 276961